Company / Operating Cash Flow per Share
PULSE BIOSCIENCES, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.82
FY2025
5-year range
-$2.12 / -$0.66
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
#148 of 161
Health Care
What the data says
Among 161 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 8% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-2.12 in FY2021 to $-0.66 in FY2024.
Based on SEC 10-K filings.
-0.82 in FY2025.
Improved from $-1.26 to $-0.82 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 161This company -$0.82 Sector average $6.64
▼
-112.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 24.6% year-over-year.
- Ranks #148 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.82 | -24.6% |
| FY2024 | -$0.66 | +47.8% |
| FY2023 | -$1.26 | +20.2% |
| FY2022 | -$1.58 | +25.3% |
| FY2021 | -$2.12 | -39.2% |
| FY2020 | -$1.52 | +7.7% |
| FY2019 | -$1.65 | -17.8% |
| FY2018 | -$1.40 | -86.2% |
| FY2017 | -$0.75 | -2.8% |
| FY2016 | -$0.73 | -66.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026